249 related articles for article (PubMed ID: 15096483)
21. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
[TBL] [Abstract][Full Text] [Related]
22. SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death.
Katz G; Krummey SM; Larsen SE; Stinson JR; Snow AL
J Immunol; 2014 May; 192(9):4202-9. PubMed ID: 24688028
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters.
Calpe S; Erdos E; Liao G; Wang N; Rietdijk S; Simarro M; Scholtz B; Mooney J; Lee CH; Shin MS; Rajnavölgyi E; Schatzle J; Morse HC; Terhorst C; Lanyi A
Immunogenetics; 2006 Feb; 58(1):15-25. PubMed ID: 16425036
[TBL] [Abstract][Full Text] [Related]
24. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
25. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
[TBL] [Abstract][Full Text] [Related]
26. The XLP syndrome protein SAP interacts with SH3 proteins to regulate T cell signaling and proliferation.
Li C; Schibli D; Li SS
Cell Signal; 2009 Jan; 21(1):111-9. PubMed ID: 18951976
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
28. Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity.
Zhong MC; Veillette A
J Biol Chem; 2008 Jul; 283(28):19255-64. PubMed ID: 18482989
[TBL] [Abstract][Full Text] [Related]
29. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
[TBL] [Abstract][Full Text] [Related]
30. Molecular and immunological basis of X-linked lymphoproliferative disease.
Latour S; Veillette A
Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
[TBL] [Abstract][Full Text] [Related]
31. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
32. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.
Tovar V; del Valle J; Zapater N; Martin M; Romero X; Pizcueta P; Bosch J; Terhorst C; Engel P
Immunogenetics; 2002 Sep; 54(6):394-402. PubMed ID: 12242590
[TBL] [Abstract][Full Text] [Related]
33. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
[TBL] [Abstract][Full Text] [Related]
34. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor.
Li C; Chung B; Tao J; Iosef C; Aoukaty A; Wang Y; Tan R; Li SS
Cell Signal; 2008 Nov; 20(11):1960-7. PubMed ID: 18662772
[TBL] [Abstract][Full Text] [Related]
35. The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
Gu C; Tangye SG; Sun X; Luo Y; Lin Z; Wu J
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14447-52. PubMed ID: 16983070
[TBL] [Abstract][Full Text] [Related]
36. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells.
Dong Z; Davidson D; Pérez-Quintero LA; Kurosaki T; Swat W; Veillette A
Immunity; 2012 Jun; 36(6):974-85. PubMed ID: 22683124
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
Ma CS; Nichols KE; Tangye SG
Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
[TBL] [Abstract][Full Text] [Related]
39. Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229.
Martín M; Del Valle JM; Saborit I; Engel P
J Immunol; 2005 May; 174(10):5977-86. PubMed ID: 15879090
[TBL] [Abstract][Full Text] [Related]
40. Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.
Menard L; Cantaert T; Chamberlain N; Tangye SG; Riminton S; Church JA; Klion A; Cunningham-Rundles C; Nichols KE; Meffre E
J Allergy Clin Immunol; 2014 Apr; 133(4):1149-61. PubMed ID: 24373350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
